Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Assets" stands at 52.86 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Total Long Term Assets" stands at 52.86 Billion USD. This represents an increase of 3.52 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 19.62 percent compared to the value the year prior.
The 1 year change in percent is 19.62.
The 3 year change in percent is 77.27.
The 5 year change in percent is 90.80.
The 10 year change in percent is 122.70.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Total Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Assets | 280,205,508,085.11 |
![]() | Novartis AG - Total Long Term Assets | 255,096,620,580.91 |